(S)-tert-Butyl (1-acetylpyrrolidin-3-yl)carbamate

Catalog No. :
ACFDKL294
CAS No. :
1013920-62-1
Molecular Formula :
C11H20N2O3
Molecular Weight :
228.29

IUPAC Name:tert-butyl (S)-(1-acetylpyrrolidin-3-yl)carbamate

(S)-tert-Butyl (1-acetylpyrrolidin-3-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$313.00Login to see priceInquiryInquiry
250mg98%$430.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-tert-Butyl (1-acetylpyrrolidin-3-yl)carbamate
IUPAC Nametert-butyl (S)-(1-acetylpyrrolidin-3-yl)carbamate
MDL No.MFCD16621191
Molecular FormulaC11H20N2O3
Molecular Weight228.29
SMILESO=C(OC(C)(C)C)N[C@@H]1CN(C(C)=O)CC1
InChI KeyLCOCMEGQRKOYAP-VIFPVBQESA-N
Synonym(S)-tert-Butyl 1-acetylpyrrolidin-3-ylcarbamate;tert-Butyl N-[(3S)-1-acetylpyrrolidin-3-yl]carbamate;Carbamic acid, N-[(3S)-1-acetyl-3-pyrrolidinyl]-, 1,1-dimethylethyl ester;(S)-1-[3-(Boc-amino)pyrrolidin-1-yl]ethanone
CAS No.1013920-62-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACFDKL294 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLIXG127 route compound structure diagram
    ACLIXG127122536-76-9 In Stock
  4. Then
  5. ACFDKL294 route product structure diagram
    ACFDKL2941013920-62-1
Inquiry

2. ACFDKL294 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLIXG127 route compound structure diagram
    ACLIXG127122536-76-9 In Stock
  4. Then
  5. ACFDKL294 route product structure diagram
    ACFDKL2941013920-62-1
Inquiry

Comments (0)